Characterization of neuroendocrine breast carcinomas for biomarkers of therapeutic options


Zoran Gatalica MD, DSc, Rebecca Feldman PhD, David Arguello MD, Anatole Ghazalpour PhD, Semir Vranic MD, PhD


Neuroendocrine breast carcinoma (NBC) is an extremely rare type of cancer, constituting less than 0.1% of all breast tumors, without specific treatment options. We investigated a biomarker database for frequency of molecular markers that may guide personalized treatment choices for these patients.

Download Publication